Skip to main content
. 2021 Sep 1;23(9):642–651. doi: 10.1089/dia.2021.0080

Table 1.

Results from T1DX-QI Telemedicine Survey

  No. of centers % of centers
Tools for conducting telemedicine visits
 Videoconferencing software only 7 33%
 Phone calls only 1 5%
 Both videoconferencing software and phone calls 13 62%
Types of software used
 Videoconference 9 43%
 Zoom 13 62%
 FaceTime® 4 19%
 Microsoft teams 2 10%
 Doximity 3 14%
 WebEx® 4 19%
 BlueJeans 1 5%
 Health system developed technology 1 5%
 Google Duo 1 5%
 WhatsApp™ 1 5%
Insurance coveragea
 Telephone visit coverage 19 95%
 Video visit coverage 20 100%
Tools used for accessing diabetes device data
 Medtronic (CareLink™) 21 100%
 Tandem t:slim (t:connect®) 21 100%
 Dexcom (Clarity®) 21 100%
 Glooko™ 20 95%
 Tidepool™ 8 38%
 Abbott Libre (LibreView™) 5 24%
 Nightscout 1 5%
Workflow for EHR download
 Either clinic staff or provider captures download 7 33%
 Clinic staff captures download 11 52%
 Provider captures download 2 10%
 Data integrated into the EHR and clinic staff provide support 1 5%
Non-MD providers participating in telemedicinea
 RD 19 95%
 CDCES 18 90%
 Social worker 16 80%
 RN 12 60%
 Psychologist 3 15%
MD and diabetes team workflowa
 Separately by phone and in conjunction with video visit 5 25%
 Separately for both 11 55%
 In conjunction for video visits 4 20%
Workflow available to support care components
 Participation of interpreters 19 90%
 Obtaining patient laboratories 13 62%
 Depression screening 8 38%
Virtual device traininga
 Provides insulin pump training using telephone or video 20 100%
 Provides CGM training using telephone or video 14 70%
Institutional goal for the overall percentage of diabetes telemedicine visits
 Unsure 12 57%
 0%–20% 2 10%
 21%–40% 4 19%
 41%–50% 3 14%
a

20 clinics reported.

CDCES, certified diabetes care and education specialist; CGM, continuous glucose monitoring; EHR; RD, registered dietitian; RN, registered nurse; T1DX-QI, T1D Exchange Quality Improvement Collaborative.